146 related articles for article (PubMed ID: 9620684)
1. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav.
O'Rourke LM; Tooze R; Turner M; Sandoval DM; Carter RH; Tybulewicz VL; Fearon DT
Immunity; 1998 May; 8(5):635-45. PubMed ID: 9620684
[TBL] [Abstract][Full Text] [Related]
2. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors.
Weng WK; Jarvis L; LeBien TW
J Biol Chem; 1994 Dec; 269(51):32514-21. PubMed ID: 7528218
[TBL] [Abstract][Full Text] [Related]
3. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway.
Salojin KV; Zhang J; Delovitch TL
J Immunol; 1999 Jul; 163(2):844-53. PubMed ID: 10395678
[TBL] [Abstract][Full Text] [Related]
4. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
[TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines.
Brooks SR; Li X; Volanakis EJ; Carter RH
J Immunol; 2000 Mar; 164(6):3123-31. PubMed ID: 10706702
[TBL] [Abstract][Full Text] [Related]
6. Signaling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, Vav, and Rac1 in human mature T lymphocytes.
Gringhuis SI; de Leij LF; Coffer PJ; Vellenga E
Mol Cell Biol; 1998 Mar; 18(3):1725-35. PubMed ID: 9488489
[TBL] [Abstract][Full Text] [Related]
7. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig.
Li X; Sandoval D; Freeberg L; Carter RH
J Immunol; 1997 Jun; 158(12):5649-57. PubMed ID: 9190913
[TBL] [Abstract][Full Text] [Related]
8. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
Bouillie S; Barel M; Frade R
J Immunol; 1999 Jan; 162(1):136-43. PubMed ID: 9886379
[TBL] [Abstract][Full Text] [Related]
9. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin.
Tooze RM; Doody GM; Fearon DT
Immunity; 1997 Jul; 7(1):59-67. PubMed ID: 9252120
[TBL] [Abstract][Full Text] [Related]
10. CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.
Yazawa N; Fujimoto M; Sato S; Miyake K; Asano N; Nagai Y; Takeuchi O; Takeda K; Okochi H; Akira S; Tedder TF; Tamaki K
Blood; 2003 Aug; 102(4):1374-80. PubMed ID: 12714520
[TBL] [Abstract][Full Text] [Related]
11. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase.
Zaffran Y; Destaing O; Roux A; Ory S; Nheu T; Jurdic P; Rabourdin-Combe C; Astier AL
J Immunol; 2001 Dec; 167(12):6780-5. PubMed ID: 11739493
[TBL] [Abstract][Full Text] [Related]
12. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
[TBL] [Abstract][Full Text] [Related]
13. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation.
Bustelo XR; Crespo P; López-Barahona M; Gutkind JS; Barbacid M
Oncogene; 1997 Nov; 15(21):2511-20. PubMed ID: 9399639
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
[TBL] [Abstract][Full Text] [Related]
15. Defective CD19-dependent signaling in B-1a and B-1b B lymphocyte subpopulations.
Sen G; Wu HJ; Bikah G; Venkataraman C; Robertson DA; Snow EC; Bondada S
Mol Immunol; 2002 Sep; 39(1-2):57-68. PubMed ID: 12213328
[TBL] [Abstract][Full Text] [Related]
16. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA
Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638
[TBL] [Abstract][Full Text] [Related]
17. Vav-dependent and vav-independent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus.
Vigorito E; Bardi G; Glassford J; Lam EW; Clayton E; Turner M
J Immunol; 2004 Sep; 173(5):3209-14. PubMed ID: 15322182
[TBL] [Abstract][Full Text] [Related]
18. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling.
Sato S; Jansen PJ; Tedder TF
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13158-62. PubMed ID: 9371816
[TBL] [Abstract][Full Text] [Related]
19. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells.
Fujikawa K; Miletic AV; Alt FW; Faccio R; Brown T; Hoog J; Fredericks J; Nishi S; Mildiner S; Moores SL; Brugge J; Rosen FS; Swat W
J Exp Med; 2003 Nov; 198(10):1595-608. PubMed ID: 14623913
[TBL] [Abstract][Full Text] [Related]
20. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
